BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3481955)

  • 21. [Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
    Mizutani S; Iwao N; Miyoshi S; Kameoka H; Yano H; Kishimoto T; Sakurai T; Wakatsuki A; Nakamura T; Honda M
    Hinyokika Kiyo; 1989 Dec; 35(12):2155-61. PubMed ID: 2694836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary report on a comparative trial of cefotetan and cefoxitin in the treatment of urinary tract infections.
    Cox CE; Childs SJ; Wells WG; Mirelmant S; Lesky WC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():227-32. PubMed ID: 6341350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Double-blind comparison of cefotetan and cefmetazole in complex urinary tract infections].
    Kamidono S; Ishigami J; Arakawa S; Umezu K; Ohmori H; Ishito N; Nihira H; Ishino T; Kurokawa K; Fujimura N
    Jpn J Antibiot; 1983 Jun; 36(6):1325-53. PubMed ID: 6361310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on long-term cinoxacin therapy for outpatients with chronic complicated urinary tract infections].
    Matsumoto J; Yamasaki Y; Katoh M; Tada S
    Hinyokika Kiyo; 1985 May; 31(5):895-900. PubMed ID: 4050634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefotetan in complicated urinary tract infections--clinical experience.
    Hautmann R; Pranada F; Pusztai-Markos Z
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():223-6. PubMed ID: 6573321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cefbuperazone in complicated urinary tract infection].
    Natsume H; Kanai S; Mitsuya E; Miyake K
    Jpn J Antibiot; 1983 Dec; 36(12):3343-8. PubMed ID: 6674546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with rational cefotetan therapy in in situ and associated surgical infections].
    Puleo S; Li Destri G; Scuderi M; Sammartino R; Romeo MA; Gismondo MR; Nicoletti G
    Ann Ist Super Sanita; 1987; 23(4):911-3. PubMed ID: 3482980
    [No Abstract]   [Full Text] [Related]  

  • 28. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
    Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
    Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experience with cefbuperazone in complicated urinary tract infection].
    Banya Y; Okamoto T; Ujiie T; Yoo T; Noro K; Niisato S; Yokota K; Aoki H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1987 May; 33(5):786-93. PubMed ID: 3661345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinical evaluation of CS-807 in patients with urinary tract infections].
    Nakajima K; Oshinoya Y; Uchibayashi T; Ohkawa M; Hisazumi H
    Hinyokika Kiyo; 1988 Aug; 34(8):1515-8. PubMed ID: 3195413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
    Gastón de Iriarte E; Cárcamo Valor P; Diez-Enciso M; Prieto Prieto J; Pérez Balcabao I; Gimeno del Sol M; Coronel Granado P; Morán Soto MJ
    Actas Urol Esp; 1995 Sep; 19(8):635-41. PubMed ID: 8669331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical application of cefotetan in pediatrics].
    Kobayashi Y; Haruta T; Okura K; Kuroki S
    Jpn J Antibiot; 1983 Jun; 36(6):1313-6. PubMed ID: 6581336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with cefotetan in the treatment of infections of children].
    Nagamatsu I; Okuno H; Takase A; Tachibana K
    Jpn J Antibiot; 1983 Jun; 36(6):1199-203. PubMed ID: 6581326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of cefotetan in pediatrics].
    Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1983 Jun; 36(6):1271-8. PubMed ID: 6581332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of ofloxacin in complicated urinary tract infection].
    Akazawa N; Tsugawa M; Hayata S; Sasaki H; Asahi T; Okita K
    Hinyokika Kiyo; 1988 Jul; 34(7):1279-82. PubMed ID: 3177148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with T-2588 in complicated urinary tract infections].
    Fukatsu H; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y; Waki M; Takamura T; Hiraiwa S; Yamada Y; Muramatsu T
    Hinyokika Kiyo; 1986 Jul; 32(7):1061-8. PubMed ID: 3776768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.